Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Benefit-risk assessment of infliximab in the treatment of rheumatoid arthritis.

PropertyValue
has minor subject area list Humans; Infliximab; Risk Assessment
information resource reference Mikuls TR, Moreland LW. Benefit-risk assessment of infliximab in the treatment of rheumatoid arthritis. Drug Saf. 2003; 26(1):23-32.
label Benefit-risk assessment of infliximab in the treatment of rheumatoid arthritis.

Search Criteria
  • Risk Benefit Assessment

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)